STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Clinical trials for STAGE IV PRIMARY PERITONEAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PRIMARY PERITONEAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV PRIMARY PERITONEAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Drug-Resistant ovarian cancer? PLX038 trial begins
Disease control Recruiting nowThis phase II trial tests a drug called PLX038 in 43 people with ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum-based chemotherapy. The drug aims to shrink tumors by blocking enzymes that help cancer cells grow. Researchers will measure how …
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 23, 2026 21:03 UTC
-
Promising combo targets recurrent gynecologic cancers
Disease control Recruiting nowThis early-stage trial is testing the drug talazoparib together with radiation therapy for people whose gynecologic cancer (ovarian, endometrial, cervical, or related cancers) has come back. The main goal is to find the safest dose and see how well the combination works at shrink…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
Could a less invasive surgery help ovarian cancer patients live longer?
Disease control Recruiting nowThis study compares two surgical approaches for people with advanced ovarian, fallopian tube, or primary peritoneal cancer who have received chemotherapy before surgery. One group will have minimally invasive surgery (small incisions) and the other will have standard open surgery…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
Heated chemotherapy during surgery: a new hope for ovarian cancer?
Disease control Recruiting nowThis study tests the safety of giving heated chemotherapy directly into the abdomen during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 participants will receive either heated chemo during surgery or standard chemo before surgery. The goal is to se…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Electric field device joins forces with cancer drugs in early trial
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to find …
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Fitbit fitness plan aims to boost immunity in cancer fight
Symptom relief Recruiting nowThis study tests whether a personalized, automated physical activity program using a Fitbit can help women with advanced ovarian or endometrial cancer exercise more and improve their quality of life. Researchers will compare the program to standard exercise advice in 120 particip…
Matched conditions: STAGE IV PRIMARY PERITONEAL CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 22, 2026 12:03 UTC